Precision medicine is more hype than reality right now — but, at the same time, the incredible potential it holds for the future is even greater than all the buzz teases today.
That’s what I came away with from the Precision Medicine Summit in Boston this week.
Let’s look into the distant future: A patient walks into a hospital to meet with clinicians who run tests and pinpoint a biomarker for, say, Alzheimer’s. Then a gene surgeon does some on-the-spot genome editing. The patient walks out with that Alzheimer’s-free-for-life feeling.